TW0006446008
TW0006446008
PHARMAESSENTIA CORP
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 493.67B EUR | 500.63B EUR | 223.14B EUR | 174.45B EUR |
Enterprise Value | 471.8B EUR | 477.18B EUR | 199.93B EUR | 152.61B EUR |
Valuation Multiples | ||||
Trailing P/E | 68.8x | 81.33x | 50.05x | 48.84x |
Forward P/E | 28.95x | -- | -- | -- |
Price to Sales | 23.79x | 29.7x | 16.4x | 14.86x |
Price to Book | 13.45x | 13.6x | 6.48x | 5.46x |
EV/Revenue | 22.74x | 28.31x | 14.7x | 13x |
EV/EBITDA | 57.94x | 60.31x | 41.79x | 39.24x |
Price to FCF (P/FCF) | 183.99x | 123.96x | 124.48x | 118.5x |
EV/FCF | 175.84x | 118.16x | 111.53x | 103.67x |
FCF Yield | 0.54% | 0.81% | 0.8% | 0.84% |